MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Sex comparisons for co-pathologies and clinical phenotypes in autopsy-confirmed four-repeat tauopathies

    E. Bayram, D. Carter, S. Aslam, E. Forbes, S. Holden (Aurora, USA)

    Objective: To assess whether co-pathologies and clinical phenotypes in people with four-repeat tauopathies (progressive supranuclear palsy [PSP], corticobasal degeneration [CBD]) differ by sex. Background: PSP…
  • 2026 International Congress

    Presence of Common Psychiatric Diagnoses Did Not Impact the Efficacy or Safety of Ecopipam in Individuals With Tourette Syndrome

    J. Mcguire, J. Flatt, G. Karkanias, F. Munschauer, T. Cunniff, S. Wanaski, E. Greenberg (Baltimore, USA)

    Objective: To evaluate ecopipam efficacy/safety in individuals with Tourette syndrome (TS) with or without common psychiatric comorbidities. Background: Co-occurring psychiatric conditions are frequently observed with…
  • 2026 International Congress

    Extended long-term follow-up of adaptive deep brain stimulation in Parkinson’s disease

    T. Herrington, A. Ramirez-Zamora, M. Beudel, S. Little, J. Ostrem, L. Almeida, A. Fasano, T. Hassell, K. Mitchell, E. Moro, N. Sarangmat, M. Gostkowski, L. Tonder, Y. Tan, R. Summers, T. Goble, S. Stanslaski, H. Bronte-Stewart (Boston, USA)

    Objective: To evaluate the extended long-term durability, programming stability, and safety of adaptive deep brain stimulation (aDBS) in people with Parkinson’s disease (PD). Background: Adaptive DBS is a recently available enhancement to continuous DBS (cDBS) that dynamically adjusts stimulation amplitude based on neural…
  • 2026 International Congress

    Urine and Plasma Bis(monoacylglycero)phosphate (BMP) in Asian LRRK2 p.G2385R and p.R1628P Variant Carriers with Parkinson’s Disease

    AN. Khairul Anuar, SY. Lim, TS. Toh, CCY. Lew, JW. Hor, YW. Tay, A. Ahmad-Annuar, L. Li, F. Hsieh, LC. Lit, AH. Tan (Kuala Lumpur, Malaysia)

    Objective: To compare urine and plasma bis(monoacylglycero)phosphate (BMP) levels in Parkinson disease (PD) patients carrying Asian-prevalent LRRK2 variants (p.G2385R, p.R1628P) against idiopathic PD (iPD) and…
  • 2026 International Congress

    Chronic Vanadium Exposure Promotes Memory Impairment and Aggregation of Alpha-Synuclein, Tau and Amyloid Beta in Mouse Brain

    O. Folarin, F. Olopade, T. Gilbert, A. Ladagu, P. Inês, O. Mustapha, L. Zethan, J. Olopade, T. Outeiro (Ibadan, Nigeria)

    Objective: In this study, we hypothesized that prolonged vanadium exposure may be a potential risk factor for Alzheimer's and Parkinson's diseases. Background: The interaction between…
  • 2026 International Congress

    Use of Mucuna Pruriens (M. Pruriens) in People with Parkinson’s Disease (PwPD)

    M. Bacigalupe, M. López, D. Merino (La Plata, Argentina)

    Objective: To characterize M. pruriens use among local (primarily Argentinian) PwPD. Background: M. pruriens is a leguminous plant used in Ayurvedic medicine to treat Parkinsonism…
  • 2026 International Congress

    Evaluation of Swallowing and Cough Function in older Patients with Parkinson’s Disease

    M. Nakamori, M. Toko, H. Yamada, R. Matsuyama, Y. Hayashi, M. Yoshikawa, T. Nagasaki, H. Maruyama (Hiroshima, Japan)

    Objective: This study aimed to characterize swallowing and cough function in older patients with Parkinson’s disease (PD) using a multidimensional assessment. Background: With population aging,…
  • 2026 International Congress

    Neuropsychiatric Symptoms in Lewy Body Disease: Monoaminergic Activity and Resting State Networks

    L. Wright, D. Burn, J. Taylor, J. O'Brien, A. Yarnall, M. Firbank, A. Thomas, R. Lawson (Newcastle, United Kingdom)

    Objective: Investigating how neuropsychiatric symptoms (NPS)—depression, anxiety, and apathy—relate to functional connectivity between monoaminergic nuclei and the limbic network (LN), default mode network (DMN), and…
  • 2026 International Congress

    Huntington’s Disease Genetic Testing Practices in the Lower North Island of New Zealand

    D. Llewelyn, D. Bourke (Wellington, New Zealand)

    Objective: This audit reviewed Huntington’s Disease (HD) diagnostic and predictive testing in New Zealand’s lower North Island. Key objectives included evaluating the frequency of pre-test…
  • 2026 International Congress

    Predictors of Secondary Non-Response to Botulinum Neurotoxin Type-A in Cervical Dystonia: A Multi-Center Egyptian Study

    E. Abed (Cairo, Egypt)

    Objective: To investigate clinical and treatment predictors of SNR in Egyptian CD patients receiving BoNT-A therapy. Background: Secondary non-response (SNR) to botulinum neurotoxin type-A (BoNT-A)…
  • « Previous Page
  • 1
  • …
  • 37
  • 38
  • 39
  • 40
  • 41
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley